Putative telomere-independent mechanisms of replicative aging reflect inadequate growth conditions.
暂无分享,去创建一个
J. Shay | W. Wright | R. Ramirez | B. Herbert | W E Wright | J W Shay | C. Morales | C P Morales | R D Ramirez | J. M. Rohde | C. Passons | B S Herbert | J M Rohde | C Passons | Ruben D. Ramirez | Jeffrey M. Rohde | C. M. Passons | Christina M. Passons
[1] R. DePinho,et al. Cellular Senescence Minireview Mitotic Clock or Culture Shock? , 2000, Cell.
[2] A. Bounacer,et al. Evidence for a Telomere-Independent “Clock” Limiting RAS Oncogene-Driven Proliferation of Human Thyroid Epithelial Cells , 2000, Molecular and Cellular Biology.
[3] J. Shay,et al. Telomere dynamics in cancer progression and prevention: fundamental differences in human and mouse telomere biology , 2000, Nature Medicine.
[4] J. Shay,et al. Telomere Shortening Is Proportional to the Size of the G-rich Telomeric 3′-Overhang* , 2000, The Journal of Biological Chemistry.
[5] J. McDougall,et al. Genetic and epigenetic changes in human epithelial cells immortalized by telomerase. , 2000, The American journal of pathology.
[6] G. Wahl,et al. Differential requirement for p19ARF in the p53-dependent arrest induced by DNA damage, microtubule disruption, and ribonucleotide depletion , 2000 .
[7] M. E. Perry,et al. The p53 Tumor Suppressor Protein Does Not Regulate Expression of Its Own Inhibitor, MDM2, Except under Conditions of Stress , 2000, Molecular and Cellular Biology.
[8] W. Hahn,et al. Human Keratinocytes That Express hTERT and Also Bypass a p16INK4a-Enforced Mechanism That Limits Life Span Become Immortal yet Retain Normal Growth and Differentiation Characteristics , 2000, Molecular and Cellular Biology.
[9] J. Shay,et al. The establishment of telomerase-immortalized cell lines representing human chromosome instability syndromes. , 2000, Human molecular genetics.
[10] R. DePinho,et al. Cellular senescence: mitotic clock or culture shock? , 2000, Cell.
[11] G. Wahl,et al. Differential requirement for p19ARF in the p53-dependent arrest induced by DNA damage, microtubule disruption, and ribonucleotide depletion. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[12] Andrea Bodnar,et al. Human Endothelial Cell Life Extension by Telomerase Expression* , 1999, The Journal of Biological Chemistry.
[13] D. Shelton,et al. Microarray analysis of replicative senescence , 1999, Current Biology.
[14] M. Newton,et al. p16/pRb pathway alterations are required for bypassing senescence in human prostate epithelial cells. , 1999, Cancer research.
[15] T. Kirkwood,et al. Positive correlation between mammalian life span and cellular resistance to stress. , 1999, Free Radical Biology & Medicine.
[16] M. White,et al. Absence of cancer–associated changes in human fibroblasts immortalized with telomerase , 1999, Nature Genetics.
[17] Xu-Rong Jiang,et al. Telomerase expression in human somatic cells does not induce changes associated with a transformed phenotype , 1999, Nature Genetics.
[18] T. Kiyono,et al. Both Rb/p16INK4a inactivation and telomerase activity are required to immortalize human epithelial cells , 1998, Nature.
[19] H. Rubin. Telomerase and cellular lifespan: Ending the debate? , 1998, Nature Biotechnology.
[20] D. Wong,et al. Inactivation of p16 in Human Mammary Epithelial Cells by CpG Island Methylation , 1998, Molecular and Cellular Biology.
[21] G. Adami,et al. Agents that cause DNA double strand breaks lead to p16INK4a enrichment and the premature senescence of normal fibroblasts , 1998, Oncogene.
[22] S. Benchimol,et al. Reconstitution of telomerase activity in normal human cells leads to elongation of telomeres and extended replicative life span , 1998, Current Biology.
[23] Bas van Steensel,et al. TRF2 Protects Human Telomeres from End-to-End Fusions , 1998, Cell.
[24] C. Harley,et al. Extension of life-span by introduction of telomerase into normal human cells. , 1998, Science.
[25] María A Blasco,et al. Telomere Shortening and Tumor Formation by Mouse Cells Lacking Telomerase RNA , 1997, Cell.
[26] H. Rubin,et al. Cell aging in vivo and in vitro , 1997, Mechanisms of Ageing and Development.
[27] F. Zindy,et al. Expression of the p16INK4a tumor suppressor versus other INK4 family members during mouse development and aging , 1997, Oncogene.
[28] S. Lowe,et al. Oncogenic ras Provokes Premature Cell Senescence Associated with Accumulation of p53 and p16INK4a , 1997, Cell.
[29] R. Wellinger,et al. Evidence for a New Step in Telomere Maintenance , 1996, Cell.
[30] J. Shay,et al. Telomerase activity in human germline and embryonic tissues and cells. , 1996, Developmental genetics.
[31] C Roskelley,et al. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[32] J. Shay,et al. The two-stage mechanism controlling cellular senescence and immortalization , 1992, Experimental Gerontology.
[33] C B Harley,et al. Telomere loss: mitotic clock or genetic time bomb? , 1991, Mutation research.
[34] A. Lewellyn,et al. Serum amine oxidase activity contributes to crisis in mouse embryo cell lines. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[35] C. Harley,et al. Telomeres shorten during ageing of human fibroblasts , 1990, Nature.
[36] D. Loo,et al. Extended culture of mouse embryo cells without senescence: inhibition by serum. , 1987, Science.
[37] Carol W. Greider,et al. Identification of a specific telomere terminal transferase activity in tetrahymena extracts , 1985, Cell.
[38] H. Micklem,et al. [Cell aging]. , 2020, Problemy gematologii i perelivaniia krovi.
[39] T. Sun,et al. Properties of an epithelial cell type in culture: the epidermal keratinocyte and its dependence on products of the fibroblast. , 1977, Progress in clinical and biological research.
[40] L. Hayflick. THE LIMITED IN VITRO LIFETIME OF HUMAN DIPLOID CELL STRAINS. , 1965, Experimental cell research.
[41] L. Hayflick,et al. THE LIMITED IN VITRO LIFETIME OF HUMAN DIPLOID CELL STRAINS 1 , 1964 .